The global intraoperative radiation therapy market was valued at US$ 121.7 million in 2024 and is projected to reach US$ 266.9 million by 2035. The industry is anticipated to grow at a CAGR of 7.4% from 2025 to 2035, driven by increasing adoption of targeted cancer treatment procedures, advancements in radiation delivery technologies, and rising demand for minimally invasive oncology solutions.
Download Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74059
Adoption of intraoperative radiation therapy is driven by growing demand for single-session treatments, short hospitalization, and quick recovery, which is in congruence with value-based care models. Enhanced workflow efficiency and reduced procedure times decrease the expense of operations while enhancing patient outcome and satisfaction, causing hospitals to adopt IORT into surgical oncology treatment protocols and multidisciplinary treatment plans.
Favorable reimbursement frameworks and recognition of IORT’s cost-effectiveness enhance institutional adoption, particularly in healthcare systems where bundled payments incentivize procedural efficiency. Miniaturization of technologies to portable devices broadens application beyond tertiary facilities. Parallel investment in training personnel, multidisciplinary planning, and capital equipment acquisition also favors integration of IORT into national surgical oncology programs.
Key Findings of the Market Report
- Based on application, demand for breast cancer management is expected to drive the market for intraoperative radiation therapy.
- A greater emphasis on mobile electron linear accelerators (LINAC) is likely to create opportunities for intraoperative radiation therapy systems to thrive in the future.
- Radiation delivery hardware and planning software are in high demand in the medical devices & clinical oncology industry.
- The dominant market share of intraoperative radiation therapy systems was held by North America in 2025.
Global Intraoperative Radiation Therapy Market: Growth Drivers
- Rising Global Prevalence of Cancer: The growing global incidence of localized malignancies, particularly breast, brain, and colorectal cancers, largely drives the market growth of intraoperative radiation therapy. Single-dose delivery options during active tumor resection provide an efficient care paradigm for growing global hospital spaces.
- Shift Towards Single-Setting Outpatient Workflows: As healthcare systems focus on reducing standard hospital stays and improving operational efficiency, treatment pathways that combine surgical resection and targeted radiotherapy into one single session become more important. These workflows eliminate weeks of external beam therapy for select clinical cases.
- Advancements in Real-Time Treatment Software: Continuous clinical research and software development are driving down planning margins while increasing target volume tracking efficiency. As a result, clinical groups are investing in advanced treatment planning systems, thereby increasing the market demand for integrated software licenses.
- Expanding Oncology Care Centers in Emerging Regions: The establishment of new standalone cancer centers across developing territories creates an ongoing demand for compact medical devices. The development of self-shielded, mobile therapeutic platforms enables standard operating rooms to host IORT setups without expensive structural shielding.
- Increasing Clinical Focus on Healthy Tissue Sparing: A growing emphasis on improving long-term survivorship quality and minimizing secondary complications drives the demand for micro-targeted radiation options. Precision applicators restrict treatment solely to the open tumor bed, shielding nearby critical organs from collateral exposure.
Global Intraoperative Radiation Therapy Market: Regional Landscape
- North America is expected to lead the market for intraoperative radiation therapy systems. Device adoption is closely tied to established healthcare capital budgets and strong therapeutic reimbursement frameworks in the United States and Canada. The North American region has seen an increase in the number of multi-center clinical validation trials, with many prominent medical centers expanding their mobile radiotherapy fleets.
- Government policies and institutional reimbursement coverage can also affect the structural demand for intraoperative oncology devices. Western European and East Asian regulatory frameworks have increasingly favored shortened clinical treatment pathways, which may drive the global demand for advanced therapeutic units. The demand for integrated oncology suites is growing beyond primary urban teaching hospitals to community-based specialty centers, contributing significantly to radiation system demand overall.
Global Intraoperative Radiation Therapy Market: Key Players
Major intraoperative radiation therapy manufacturers are using several organic and inorganic growth strategies to expand their market presence. Their production capability is being expanded to meet the increase in demand.
- Zeiss Group (Carl Zeiss Meditec AG)
- iCAD, Inc.
- IntraOp Medical, Inc.
- Arios SAS (Sordina IORT Technologies)
- Elekta AB
- Varian Medical Systems, Inc. (A Siemens Healthineers Company)
- Eckert & Ziegler BEBIG
- Xoft, Inc. (A subsidiary of iCAD, Inc.)
- GMV Innovating Solutions
- Sensus Healthcare, Inc.
Key Developments
- In January 2026, IntraOp Medical announced that it had received updated regulatory clearance for its advanced electron-beam system, enabling automated real-time electron flash delivery protocols during standard surgical procedures to protect deeper critical anatomical zones.
- In March 2026, Carl Zeiss Meditec showcased an expanded partnership with international healthcare networks to supply self-shielded miniature x-ray sources to emerging surgical oncology setups throughout the Asia-Pacific region, fast-tracking setup installations.
Global Intraoperative Radiation Therapy Market: Segmentation
- By Technology
- Electron IORT
- Intraoperative Brachytherapy
- By Product & Service
- Systems & Accelerators
- Applicators & Afterloaders
- Treatment Planning Systems
- Accessories & Consumables
- Services (Maintenance & Dosimetry Validation)
- By Application
- Breast Cancer
- Brain Tumors
- Gastrointestinal Cancer
- Colorectal Cancer
- Head & Neck Cancer
- Others (Sarcomas and Gynecological Cancers)
- By End User
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Specialty Oncology Clinics
- By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=74059<ype=S
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com